Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.33 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22939488 | 1.00 | KDM4E (0.42) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL22939042 | 1.00 | KDM4E (0.42) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL22939117 | 0.91 | KDM4E (0.42) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL25635029 | 0.89 | KDM4E (0.48) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL25635031 | 0.89 | KDM4E (0.48) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL17146741 | 0.89 | KDM4E (0.48) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL12521348 | 0.89 | KDM4E (0.48) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL25635028 | 0.89 | KDM4E (0.48) | KDM4EL3MBTL1ATMMEN1ALDH1A1 | |
| SCHEMBL22939674 | 0.87 | KDM4E (0.32) | KDM4EL3MBTL1ATM | |
| SCHEMBL25635035 | 0.86 | KDM4E (0.46) | KDM4EL3MBTL1ATMMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708355-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210032225-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032225-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, BRD1 | KDM4E 1758/4885L3MBTL1 571/4885ATM 3797/4885 |
| US-11708355-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, BRD1 | KDM4E 1758/4885L3MBTL1 571/4885ATM 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.